Condition: Autism Spectrum Disorder · Language Disorders · Sponsor: Southwest Autism Research & Resource Center
The primary objective of this study is to evaluate the cognitive and behavioral effects of liquid leucovorin calcium on young children with autism spectrum disorder (ASD) and determine whether it improves social communication as well as the core and associated symptoms of ASD. The investigators will enroll 80 children across two sites, between the ages of 2.5 and 5 years, with confirmed ASD and known social and communication delays. Participation will last approximately 26 weeks, from screening visit to end of treatment.
This description comes directly from the study's public registry record.
Richard E Frye, MD, PhD · (321) 259-7111 · DrFrye@RossignolMedicalCenter.com
Always discuss trial participation with your own doctor first.
| Southwestern Research & Resource Center | Phoenix, Arizona, United States | Not Yet Recruiting |
| State University of New York, Downstate | Brooklyn, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04060030